LOWELL, Mass., April 05, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Steven Raters as Vice President of Global Technical Services. Steven will report directly to the CEO, Robert Spignesi.
Mr. Raters brings over 25 years of customer service experience in the medical device and diagnostics industry. Most recently, he held the position of Senior Director of Service Transformation in Latin America at bioMérieux, where he focused on standardization and optimization of service delivery in a high sales growth region. Mr. Raters held multiple service and operations leadership roles at bioMérieux, including managing a team of almost 200 customer support, field application and field service employees. Mr. Raters’ prior roles included positions at Organon Teknika Corp and with the United Sates Navy.
“I am thrilled to welcome a key leader with experience like Steven to join our executive team,” said CEO Robert Spignesi. “His track record of building high performing service organizations and substantially improving customer satisfaction, revenue and profitability will be instrumental to our continued growth and success.”
“I am pleased to join the team at Rapid Micro Biosystems and take on this assignment during an exciting phase of the company’s development,” said Mr. Raters. “I look forward to building a high quality service organization capable of delivering world-class customer experience.”
Steven holds a B.S. in Business Management and an MBA from the University of Phoenix.
About Rapid Micro Biosystems:
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology, first developed and patented by Dr. Don Straus, Ph.D., uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


Italy Fines Apple €98.6 Million Over App Store Dominance
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



